Literature DB >> 17301640

CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention.

Helmut Gohlke1, Moritz Winter, Marthin Karoff, Klaus Held.   

Abstract

AIMS: Risk stratification is important for decisions about the intensity of treatment in primary prevention. Risk factors and lifestyle factors are responsible for over 80% of cardiovascular morbidity and mortality. However, body mass index (BMI), physical activity and smoking (cigarettes/day) are not or not quantitatively represented in the risk stratification system. METHODS AND
RESULTS: CARdiovascular RISk MAnagement (CARRISMA) is a software program considering the prognostic impact of BMI, physical activity and cigarettes per day adjusted for age and sex based on multivariate regression analyses from the literature on top of one of the three major scores to improve risk stratification. The 10-year European Society of Cardiology Systematic COronary Risk Evaluation (SCORE) cardiovascular mortality risk for an intermediate risk region, e.g. increases from 3 to 6% by considering smoking of 30 cigarettes per day instead of just 'smoking' and by taking into account a BMI of 34. Whereas the 10-year ESC cardiovascular mortality risk of a 55-year-old active individual decreases from 5 to 3%, by considering a physical activity equivalent of 2100 kcal/week, the Framingham or PROspective CArdiovascular Münster (PROCAM) risks change accordingly.
CONCLUSION: CARRISMA facilitates the application of knowledge of the current literature in the individual patient in a user-friendly manner allowing a more detailed and yet time-efficient risk stratification and risk management in primary prevention, particularly in the intermediate risk range.

Entities:  

Mesh:

Year:  2007        PMID: 17301640     DOI: 10.1097/01.hjr.0000244581.30421.69

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  6 in total

1.  [Primary prevention of coronary artery disease: is there a role for risk scores?].

Authors:  H Gohlke
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

2.  [Systemic cardiovascular risk assessment. Conventional or eye fundus-based?].

Authors:  A Wolf; M Kernt; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

3.  Cardiovascular prevention in clinical practice (ESC and German guidelines 2007).

Authors:  Helmut Gohlke; Christian Albus; Detlef Bernd Gysan; Harry W Hahmann; Peter Mathes
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

4.  [Primary prevention of coronary heart disease : Evidence-based drug treatment].

Authors:  Franziska Mühleck; Ulrich Laufs
Journal:  Herz       Date:  2020-02       Impact factor: 1.443

5.  Exercise Effects on Risk of Cardiovascular Disease among Iranian Women.

Authors:  Farkhondeh Amin-Shokravi; Reza Rajabi; Nargess Ziaee
Journal:  Asian J Sports Med       Date:  2011-03

6.  Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts.

Authors:  Viktoria Rücker; Ulrich Keil; Anthony P Fitzgerald; Uwe Malzahn; Christof Prugger; Georg Ertl; Peter U Heuschmann; Hannelore Neuhauser
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.